Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and Carcinoma, Non-Small Cell Lung

erythromycin has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, M; Li, C; Li, T; Li, Y; Qi, Q; Wang, A; Wang, B; Xu, L; Zhang, Y1
Barletta, E; Cusano, F; Ferrara, G; Ingordo, V1
Hamada, K; Kita, E; Mikasa, K; Narita, N; Sakamoto, M; Sawaki, M; Teramoto, S1
Goto, G; Ieshiro, R; Iguchi, M; Okamura, J; Ota, T; Yuasa, K1
Kita, E; Konishi, M; Maeda, K; Majima, T; Mikasa, K; Murakawa, K; Narita, N; Sakamoto, M; Takahashi, K; Yoshimoto, E1

Trials

3 trial(s) available for erythromycin and Carcinoma, Non-Small Cell Lung

ArticleYear
Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
    Thoracic cancer, 2018, Volume: 9, Issue:8

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cyclobutanes; Erythromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Pleural Effusion, Malignant; Prospective Studies; Survival Analysis; Treatment Outcome

2018
[Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Jan-10, Volume: 86, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Mice; Middle Aged

1997
[Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period].
    The Japanese journal of antibiotics, 2000, Volume: 53 Suppl A

    Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Erythromycin; Female; Humans; Immunologic Factors; Lung Neoplasms; Male; Retrospective Studies

2000

Other Studies

2 other study(ies) available for erythromycin and Carcinoma, Non-Small Cell Lung

ArticleYear
Erlotinib-induced pustular eruption.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:1

    Topics: Acneiform Eruptions; Administration, Cutaneous; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythromycin; Gels; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome

2009
[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
    The Japanese journal of antibiotics, 1997, Volume: 50 Suppl A

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Clarithromycin; Erythromycin; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Male; Survival Rate

1997